Literature DB >> 23356205

Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance.

Franciszek Iwańczak1, Barbara Iwańczak.   

Abstract

In the present work, the problem of Helicobacter pylori infection in the world and its increasing antibiotic resistance are analyzed. The authors discuss the efficacy of treatment, noting that the clarithromycin--and metronidazole-resistance of H. pylori is the main cause of this treatment failure. Because of this phenomenon, a quadruple therapy is being introduced and clarithromycin is being replaced by new antibiotics. The authors also present various schemes of triple and quadruple therapy as well as sequential therapy. Attention is directed to the fact that, in order to obtain better results of the eradication, the treatment should be prolonged from 7 to 10 or even 14 days, and that the doses of the drugs should be increased.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23356205

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  13 in total

Review 1.  Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance.

Authors:  Sinéad M Smith; Colm O'Morain; Deirdre McNamara
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection.

Authors:  Soracha Thamphiwatana; Weiwei Gao; Dissaya Pornpattananangkul; Qiangzhe Zhang; Victoria Fu; Jiayang Li; Jieming Li; Marygorret Obonyo; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

Review 3.  Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery.

Authors:  Marilia Carabotti; Chiara D'Ercole; Angelo Iossa; Enrico Corazziari; Gianfranco Silecchia; Carola Severi
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 4.  Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems.

Authors:  Mahdi Karimi; Amir Ghasemi; Parham Sahandi Zangabad; Reza Rahighi; S Masoud Moosavi Basri; H Mirshekari; M Amiri; Z Shafaei Pishabad; A Aslani; M Bozorgomid; D Ghosh; A Beyzavi; A Vaseghi; A R Aref; L Haghani; S Bahrami; Michael R Hamblin
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

Review 5.  Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis.

Authors:  Youhua Wang; Rulin Zhao; Ben Wang; Qiaoyun Zhao; Zhen Li; Liya Zhu-Ge; Wenzhu Yin; Yong Xie
Journal:  Eur J Clin Pharmacol       Date:  2017-10-08       Impact factor: 2.953

Review 6.  Helicobacter pylori colonization of the oral cavity: A milestone discovery.

Authors:  John K C Yee
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 7.  Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.

Authors:  Alexander A Nijevitch; Bulat Idrisov; Elsa N Akhmadeeva; David Y Graham
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Antibiotics resistance of Helicobacter pylori and treatment modalities in children with H. pylori infection.

Authors:  Ji-Hyun Seo; Hyang-Ok Woo; Hee-Shang Youn; Kwang-Ho Rhee
Journal:  Korean J Pediatr       Date:  2014-02-24

9.  The Helicobacter pylori eradication in the group receiving standard -dose and group continue taking amoxicillin for 4 weeks; a clinical trial study.

Authors:  Mohammad Javad Ehsani-Ardakani; Meghdad Sedaghat; Gyti Eslami; Hamid Mohaghegh Shalmani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

Review 10.  Helicobacter pylori CagA: From Pathogenic Mechanisms to Its Use as an Anti-Cancer Vaccine.

Authors:  Markus Stein; Paolo Ruggiero; Rino Rappuoli; Fabio Bagnoli
Journal:  Front Immunol       Date:  2013-10-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.